BMJ: We must have raw data for Covid-19 vaccines and treatments now

“despite the global rollout of Covid-19 vaccines and treatments, the anonymised participant level data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public—and are likely to remain that way for years to come....More...